Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Vaccines for preventing influenza in healthy children

This is not the most recent version

Information

DOI:
https://doi.org/10.1002/14651858.CD004879.pub4Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 15 August 2012see what's new
Type:
  1. Intervention
Stage:
  1. Review
Cochrane Editorial Group:
  1. Cochrane Acute Respiratory Infections Group

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Tom Jefferson

    Correspondence to: Cochrane, Roma, Italy

    [email protected]

    [email protected]

  • Alessandro Rivetti

    Dipartimento di Prevenzione ‐ S.Pre.S.A.L, ASL CN2 Alba Bra, Alba, Italy

  • Carlo Di Pietrantonj

    Regional Epidemiology Unit SeREMI, Local Health Unit Alessandria‐ ASL AL, Alessandria, Italy

  • Vittorio Demicheli

    Servizio Regionale di Riferimento per l'Epidemiologia, SSEpi‐SeREMI ‐ Cochrane Vaccines Field, Azienda Sanitaria Locale ASL AL, Alessandria, Italy

  • Eliana Ferroni

    Department of Epidemiology, Lazio Regional Health Service, Rome, Italy

Contributions of authors

Tom Jefferson (TOJ) co‐wrote Background and Methods, Results and Discussion (efficacy and effectiveness) and interpreted the data.
Alessandro Rivetti (AR) conducted searches, co‐ordinated retrieval of papers, identified papers for inclusion, extracted and checked data.
Eliana Ferroni (EF) applied inclusion criteria, co‐extracted studies and wrote the paragraph on safety.
Carlo Di Pietrantonj (CDP) constructed comparisons for meta‐analysis, checked data, identified papers for inclusion, analysed data, wrote statistical methods, co‐wrote Results and interpreted the data.
Vittorio Demicheli (VD) co‐wrote Background and Methods, determined papers for inclusion, arbitrated on quality assessment, constructed comparisons for meta‐analysis and did a critical review of the existing review.
All authors contributed to and approved the revised text.

Sources of support

Internal sources

  • REGIONE PIEMONTE ASL 20 ALESSANDRIA, Italy.

    for 2007 update, now ASL AL for 2012 update

  • MRC Programme Grant G0000340, UK.

External sources

  • No sources of support supplied

Declarations of interest

Tom Jefferson was an ad hoc consultant for F. Hoffman‐La Roche Ltd in 1998 to 1999 on oseltamivir. He receives royalties from his books published by Blackwell and Il Pensiero Scientifico Editore, none of which are on neuraminidase inhibitors. He is occasionally interviewed by market research companies for anonymous interviews about Phase 1 or 2 products unrelated to influenza. He is acting as expert witness for the plaintiff in a legal case for claimed damages after exposure to a pandemic monovalent vaccine.

Acknowledgements

Regione Piemonte, Italy funded the study together with the UK National Institute for Health Research (NIHR) Cochrane Review Incentive Scheme 2011. Oxford Childhood Infection Study, University of Oxford, UK (from MRC Programme Grant G0000340), funded previous versions of the study. Ruth Foxlee previously advised on search strategies and carried out duplicate searches. Vassily Vlassov and Frances Tilling carried out translations from Russian. Melanie Rudin provided logistical support. Gabriella Morandi attended to paper retrieval. The review authors would like to thank Dr Kenneth Zangwill (ab Zangwill 2001) and Dr Jonathan Crofts (cb Nicholls 2004) for providing further data for use in the review. The review authors also wish to thank the following people for commenting on drafts of this review: Amy Zelmer, Leslie Goldstein, Mark Jones, George Swingler, Lamberto Manzoli, Márcia Alves Galvão, Robert Ware and John Holden. Sue Smith, Anthony Harnden and Nicholas J Matheson co‐authored previous versions of the review.

Version history

Published

Title

Stage

Authors

Version

2018 Feb 01

Vaccines for preventing influenza in healthy children

Review

Tom Jefferson, Alessandro Rivetti, Carlo Di Pietrantonj, Vittorio Demicheli

https://doi.org/10.1002/14651858.CD004879.pub5

2012 Aug 15

Vaccines for preventing influenza in healthy children

Review

Tom Jefferson, Alessandro Rivetti, Carlo Di Pietrantonj, Vittorio Demicheli, Eliana Ferroni

https://doi.org/10.1002/14651858.CD004879.pub4

2008 Apr 23

Vaccines for preventing influenza in healthy children

Review

Tom Jefferson, Alessandro Rivetti, Anthony Harnden, Carlo Di Pietrantonj, Vittorio Demicheli

https://doi.org/10.1002/14651858.CD004879.pub3

2006 Jan 25

Vaccines for preventing influenza in healthy children

Review

Sue Smith, Vittorio Demicheli, Carlo Di Pietrantonj, Anthony R Harnden, Tom Jefferson, Nicholas J Matheson, Alessandro Rivetti

https://doi.org/10.1002/14651858.CD004879.pub2

2004 Jul 19

Vaccines for preventing influenza in healthy children

Protocol

Sue Smith, Vittorio Demicheli, Tom Jefferson, Anthony R Harnden, Nicholas J Matheson, Carlo Di Pietrantonj

https://doi.org/10.1002/14651858.CD004879

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.